DK162255C - Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf - Google Patents

Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf

Info

Publication number
DK162255C
DK162255C DK254585A DK254585A DK162255C DK 162255 C DK162255 C DK 162255C DK 254585 A DK254585 A DK 254585A DK 254585 A DK254585 A DK 254585A DK 162255 C DK162255 C DK 162255C
Authority
DK
Denmark
Prior art keywords
plunger pipe
preparation
plate
damper
aural
Prior art date
Application number
DK254585A
Other languages
Danish (da)
English (en)
Other versions
DK254585A (da
DK254585D0 (da
DK162255B (da
Inventor
Ulrich Grau
Gerhard Ross
Dietrich Hiller
Horst Paul Neubauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843443877 external-priority patent/DE3443877A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK254585D0 publication Critical patent/DK254585D0/da
Publication of DK254585A publication Critical patent/DK254585A/da
Publication of DK162255B publication Critical patent/DK162255B/da
Application granted granted Critical
Publication of DK162255C publication Critical patent/DK162255C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
DK254585A 1984-06-09 1985-06-06 Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf DK162255C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3421615 1984-06-09
DE3421615 1984-06-09
DE3421613 1984-06-09
DE3421613 1984-06-09
DE3443877 1984-12-01
DE19843443877 DE3443877A1 (de) 1984-06-09 1984-12-01 Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung

Publications (4)

Publication Number Publication Date
DK254585D0 DK254585D0 (da) 1985-06-06
DK254585A DK254585A (da) 1985-12-10
DK162255B DK162255B (da) 1991-10-07
DK162255C true DK162255C (da) 1992-03-16

Family

ID=27192050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK254585A DK162255C (da) 1984-06-09 1985-06-06 Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf

Country Status (16)

Country Link
EP (1) EP0166971B1 (fi)
AT (1) ATE50502T1 (fi)
AU (1) AU575951B2 (fi)
CA (1) CA1258427A (fi)
DE (1) DE3576120D1 (fi)
DK (1) DK162255C (fi)
ES (1) ES8605679A1 (fi)
FI (1) FI80596C (fi)
GR (1) GR851393B (fi)
HU (1) HU200102B (fi)
IE (1) IE57998B1 (fi)
IL (1) IL75448A (fi)
NO (1) NO164277C (fi)
NZ (1) NZ212338A (fi)
PH (1) PH24118A (fi)
PT (1) PT80620B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179479C (no) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
LT3228320T (lt) 2008-10-17 2020-03-10 Sanofi-Aventis Deutschland Gmbh Insulino ir glp-1 agonisto derinys
PE20121362A1 (es) 2009-11-13 2012-10-17 Sanofi Aventis Deutschland Composicion farmaceutica que comprende despro36exendina-4(1-39)-lys6-nh2, insulina gly(a21)-arg(b31)-arg(b32) y metionina
KR101772372B1 (ko) 2009-11-13 2017-08-29 사노피-아벤티스 도이칠란트 게엠베하 Glp-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
EP2611458B1 (en) 2010-08-30 2016-09-21 Sanofi-Aventis Deutschland GmbH Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
MX369511B (es) 2013-04-03 2019-11-11 Sanofi Sa Tratamiento de la diabetes mellitus mediante formulaciones de insulinas de acción prolongada.
HRP20230470T1 (hr) 2014-12-12 2023-07-21 Sanofi-Aventis Deutschland Gmbh Formulacija fiksnog omjera inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2574889A (en) * 1947-10-06 1951-11-13 Leo Ab Methylated gelatin-insulin preparation
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
ZW17382A1 (en) * 1981-08-27 1982-11-17 Lilly Co Eli Human proinsulin pharmaceutical formulations
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
WO1985005036A1 (en) * 1984-04-30 1985-11-21 The Trustees Of Columbia University In The City Of Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch

Also Published As

Publication number Publication date
IE57998B1 (en) 1993-06-02
ES543972A0 (es) 1986-01-16
HU200102B (en) 1990-04-28
FI80596C (fi) 1990-07-10
DE3576120D1 (de) 1990-04-05
DK254585A (da) 1985-12-10
DK254585D0 (da) 1985-06-06
EP0166971A1 (de) 1986-01-08
FI852273A0 (fi) 1985-06-06
FI80596B (fi) 1990-03-30
ATE50502T1 (de) 1990-03-15
EP0166971B1 (de) 1990-02-28
HUT37893A (en) 1986-03-28
CA1258427A (en) 1989-08-15
IL75448A (en) 1989-07-31
PT80620A (de) 1985-07-01
NO164277C (no) 1990-09-19
IL75448A0 (en) 1985-10-31
DK162255B (da) 1991-10-07
NO164277B (no) 1990-06-11
ES8605679A1 (es) 1986-01-16
AU575951B2 (en) 1988-08-11
FI852273L (fi) 1985-12-10
NO852314L (no) 1985-12-10
GR851393B (en) 1985-11-25
IE851431L (en) 1985-12-09
AU4342485A (en) 1985-12-12
PT80620B (pt) 1987-10-20
PH24118A (en) 1990-03-05
NZ212338A (en) 1989-02-24

Similar Documents

Publication Publication Date Title
DK162255C (da) Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf
IT7869848A0 (it) Valvola per fluidi con strozzatore di flusso
DK198388A (da) Hydrofob silica samt fremgangsmaade til fremstilling og anvendelse af denne
BE872678A (fr) Valve pour regler la circulation d'un fluide
IT8920547A0 (it) Analizzatore di fluidi con compensazione.
IT1155262B (it) Dispositivo per l'aspirazione della polvere prodotta da un trapano in prossimita del punto di trapanatura
DK556487A (da) Gennemstroemningsvolumenmaaler til flydende medier
DE59906300D1 (de) Fluidischer Stossdämpfer
ES2048369T3 (es) Tratamiento de metal liquido.
FR2575052B3 (fr) Dispositif destine a equiper un presentoir, ou similaire, pour servir de support a une serie de tiges de suspension d'articles divers, et meubles presentoirs equipes d'un tel dispositif
DE3681284D1 (de) Schwingungsdaempfer fuer maschinenlagerungen.
BE881461A (fr) Dispositif de controle pour le liquide de refroidissement de compresseurs travaillant avec injection de liquide
IT1138611B (it) Valvola di ritegno per fluidi
SE8105745L (sv) Borttagbar tetning for askfickor och liknande
IT8917412A0 (it) Metodo per diminuire il peso specifico di un liquido in cui e' immerso un corpo, insufflando gas.
MY101782A (en) Method for removing a volatile material from a liquid and equipment for the working of this method
ES257901U (es) Cabeza tomamuestras para medidor de velocidad de sedimenta- cion de sangre
UA8634A1 (uk) Спосіб видалеhhя рідиhи з вибою свердловиhи
UA39943C2 (uk) Компенсатор енергії
SE8504611D0 (sv) Vattenpump
SE8603824L (sv) Leckageindikator
IT9021368A0 (it) Dispositivo per equilibrare la portata di pompe di iniezione del carburante
IT8041572A0 (it) Procedimento per determinare la profondita' di giacitura di uno strato saturo di fluido e il tipo di fluido.
ES288427U (es) Molde para congelar liquidos
ES262731U (es) Soporte de motor de dos camaras con amortiguacion hidraulica.

Legal Events

Date Code Title Description
PUP Patent expired